Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Concordia Healthcare Corp. T.CXR.R



TSX:CXR.R - Post by User

Comment by Lumberfeverlongon Oct 07, 2016 1:22pm
106 Views
Post# 25323309

RE:$280M per year not counted in the adjusted EBITDA??

RE:$280M per year not counted in the adjusted EBITDA??What's your point exactly?  Adjusted EBITDA should come in at about $240m for H2 2016. Extrapolating  to 2017 and assuming no growth free cash flow should come in at $480M-280M-$30M(principal payments approximate number)=$170M. 

I would expect  the company to invest heavily over the next twelve months to bring new products to market and buy small portfolios from third parties with the cash they will raise from the note issuance.  

The importance of the note offering cannot be understated. It gives the company the flexibility it needs to execute on a renewed business plan. Yes, they can no longer rely on significant price increases to achieve aggressive prior profit margin targets. Those margins will be narrower, but they really only need to be higher than debt servicing costs. They don't have to be 70%. 30% margins is all they need to achieve to grow EBITDA over time by continually deploying capital on product launches and product acquisitions.

What at the shorts don't get is that this is not a static business. The board and management are readjusting to the new reality and the current capital raise gives them ample flexibility to do so.  

Continue shorting at at your own peril.  


PROtrading wrote:
The $280M in interest payments alone are not counted in the "adjusted EBITDA"

OK, that's freaking funny no? 

No wonder they want to flush all the debt holders and all those payments and liability by selling the Notes (company) to fellow "street"!  And if secured debt holders get flushed, shareholders go first.

SWOSSSHHHHHH  I hear the toilet bowl already!


<< Previous
Bullboard Posts
Next >>